IP Library Granted Patent US 9,238,797
Granted Patent B2
US 9,238,797 · App. 13/003,262 · Granted Jan 19, 2016

Method for production of pluripotent stem cell

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,238,797
App. No.
13/003,262
Granted
Jan 19, 2016
Kind
B2
Abstract

The present invention relates to a method for production of a cell population containing a pluripotent stem cell, said method comprising a step of treating a somatic cell which has been contacted with nuclear reprogramming factors under nutrient-starved condition, and/or a step of treating the somatic cell with an agent capable of arresting cell cycle. The present invention allows induction and growth of pluripotent stem cells at high frequency, and it also allows production of pluripotent stem cells with high efficiency. The nuclear reprogramming factors to be used may be any selected from the group consisting of OCT4, SOX2, c-MYC, KLF4, NANOG and LIN28.

Claims (3)

1. A method for production of a cell population containing a pluripotent stem cell, said method comprising a step of infecting a somatic cell with a retrovirus vector(s) carrying genes encoding nuclear reprogramming factors in the presence of a sole functional substance having an activity of binding to a retrovirus and an activity of improving pluripotent stem cell induction efficiency, wherein the functional substance consists of a fibronectin fragment of full-length fibronectin having a heparin-II binding region.

2. The method according to claim 1 , wherein the somatic cell is infected with a retrovirus vector(s) carrying genes encoding the nuclear reprogramming factors selected from the group consisting of OCT4, SOX2, c-MYC, KLF4, NANOG and LIN28.

3. A method for production of a pluripotent stem cell, said method comprising a step of producing a cell population containing a pluripotent stem cell by the method as defined in claim 1 , and a step of isolating a pluripotent stem cell from the resulting cell population.

Assignments (3)
CHANGE OF ADDRESS Recorded Jun 24, 2016
From: TAKARA BIO INC.
To: TAKARA BIO INC.
Reel/Frame 039152/0834 →
CORRECTIVE ASSIGNMENT TO CORRECT THE FIRST NAME OF THE FIRST INVENTOR TO READ TATSUJI INSTEAD OF TASUJI AS PREVIOUSLY RECORDED ON REEL 025983 FRAME 0858. ASSIGNOR(S) HEREBY CONFIRMS THE FIRST NAME OF THE FIRST INVENTOR IS TATSUJI.. Recorded May 11, 2012
From: ENOKI, TATSUJI; IWAMOTO, FUMIKO; NISHIE, TOSHIKAZU; MARUI, TAKAHIRO; TAKASHIMA, FUYUKO; KATO, IKUNOSHIN
To: TAKARA BIO INC.
Reel/Frame 028193/0950 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2011
From: ENOKI, TASUJI; IWAMOTO, FUMIKO; NISHIE, TOSHIKAZU; MARUI, TAKAHIRO; TAKASHIMA, FUYUKO; KATO, IKUNOSHIN
To: TAKARA BIO INC.
Reel/Frame 025983/0858 →